Larisa Gavrilova-Jordan

Professor

Larisa Gavrilova-Jordan

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Obstetrics and Gynecology: Reproductive Endocrinology, Infertility, and Genetics

Bio

Dr. Gavrilova-Jordan is an exceptional physician with a broad range of clinical skills and interests. She is a director of the In-Vitro Fertilization Service and leads the Fertility Preservation program at Augusta University. Dr. Gavrilova-Jordan received her medical degree with Distinction in Southern Russia. She performed her residency in Obstetrics in Gynecology at Mayo Clinic, Rochester, M.N., and later completed a Fellowship in Reproductive Endocrinology and Infertility at Duke University Medical Center in Durham, N.C.

  • (706) 721-3832
  • BB 7516A

Education

  • MD, Medicine Kuban State Medical Academy, 1998

Certifications

  • PHY Georgia Composite Med Board, 2013

  • Reproductive Endocrinology and Infertility ABOG, 2012

Awards & Honors

  • Top Doctor Healthgrades, 2015

  • CREST Scholarship 2009

Courses Taught Most Recent Academic Year

  • ROBG 5000

    Obstetrics and Gynecology
  • OBGN 5000

    Basic Clkshp OBGYN
  • OBGN 5006

    Reproductive Endocrinology Ext

Scholarship

Selected Recent Publications

  • Optical Genome Mapping and Single Nucleotide Polymorphism Microarray: An Integrated Approach for Investigating Products of Conception., 2022
    Journal Article, Academic Journal
  • Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis., 2021
    Journal Article, Academic Journal
  • Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report., 2021
    Other
  • Regional disparities in access to assisted reproductive technology: assessment of patient satisfaction when employing modern technology to close the gap., 2021
    Journal Article, Academic Journal
  • Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature., 2020
    Journal Article, Academic Journal